We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+14.43%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$340M
AUM Growth
-$60.2M
(-15%)
Cap. Flow
-$87.3M
Cap. Flow
% of AUM
-25.71%
Top 10 Holdings %
Top 10 Hldgs %
46.41%
Holding
483
New
151
Increased
11
Reduced
18
Closed
302
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AZEK
The AZEK Co
AZEK
|
+$58.6M |
| 2 |
RDFN
Redfin
RDFN
|
+$35.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.53M |
| 4 |
Sprouts Farmers Market
SFM
|
+$7.45M |
| 5 |
Insmed
INSM
|
+$5.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$30.3M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.3M |
| 3 |
ExxonMobil
XOM
|
+$11.3M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$10.8M |
| 5 |
Pfizer
PFE
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 31.47% |
| 2 | Real Estate | 13.23% |
| 3 | Healthcare | 10.04% |
| 4 | Financials | 9.26% |
| 5 | Consumer Discretionary | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Central Garden & Pet Co
CENT
$2.72B
| – | – |
-12,500
| Closed | -$458K |
|
227
Certara
CERT
$1.17B
| – | – |
-62,710
| Closed | -$621K |
|
228
Citizens Financial Group
CFG
$30.4B
| – | – |
-34,700
| Closed | -$1.42M |
|
229
C.H. Robinson
CHRW
$22.9B
| – | – |
-13,800
| Closed | -$1.41M |
|
230
Citizens
CIA
$245M
| – | – |
-10,480
| Closed | -$47.7K |
|
231
Cincinnati Financial
CINF
$28B
| – | – |
-1,600
| Closed | -$236K |
|
232
Colgate-Palmolive
CL
$72.4B
| – | – |
-6,725
| Closed | -$630K |
|
233
Calumet Specialty Products
CLMT
$3.65B
| – | – |
-44,436
| Closed | -$563K |
|
234
Clover Health Investments
CLOV
$2.33B
| – | – |
-311,651
| Closed | -$1.12M |
|
235
ClearPoint Neuro
CLPT
$432M
| – | – |
-15,582
| Closed | -$185K |
|
236
Comcast
CMCSA
$79.7B
| – | – |
-48,800
| Closed | -$1.8M |
|
237
Capital One
COF
$124B
| – | – |
-1,775
| Closed | -$318K |
|
238
Coherent
COHR
$56.4B
| – | – |
-15,974
| Closed | -$1.04M |
|
239
Coinbase
COIN
$41.7B
| – | – |
-2,822
| Closed | -$486K |
|
240
Cencora
COR
$60B
| – | – |
-11,400
| Closed | -$3.17M |
|
241
Capri Holdings
CPRI
$1.8B
| – | – |
-18,100
| Closed | -$357K |
|
242
California Resources
CRC
$4.77B
| – | – |
-32,700
| Closed | -$1.44M |
|
243
Crescent Energy
CRGY
$3.75B
| – | – |
-20,900
| Closed | -$235K |
|
244
Carter's
CRI
$1.42B
| – | – |
-30,243
| Closed | -$1.24M |
|
245
Corvus Pharmaceuticals
CRVS
$1.11B
| – | – |
-36,421
| Closed | -$116K |
|
246
Cisco
CSCO
$449B
| – | – |
-48,100
| Closed | -$2.97M |
|
247
CuriosityStream
CURI
$141M
| – | – |
-17,612
| Closed | -$47.2K |
|
|
CWAN
248
DELISTED
Clearwater Analytics
CWAN
| – | – |
-15,100
| Closed | -$405K |
|
249
Cemex
CX
$17.6B
| – | – |
-115,174
| Closed | -$646K |
|
250
Delta Air Lines
DAL
$56.1B
| – | – |
-23,950
| Closed | -$1.04M |
|
Similar funds
FS
BC
HAM
DP
SPC
IW
SRHG
MPW
Quantessence Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Quantessence Capital held 483 positions worth $340M, down 15% from $400M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Quantessence Capital withdrew a net $87.3M in Q2 2025, closing 302 positions and reducing 18 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $30.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 11% a quarter earlier, followed by Real Estate and Healthcare.
Against the trend, Quantessence Capital opened a new position in The AZEK Co worth $63.6M.
- Quantessence Capital's largest Q2 2025 buy was The AZEK Co: 1,170,131 shares worth $63.6M.
- Quantessence Capital added most to Merck in Q2 2025, an estimated $3.19M increase.
- Quantessence Capital's biggest Q2 2025 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $1.84M.
- Quantessence Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $30.3M.
- Quantessence Capital's ten largest holdings make up 46% of its $340M portfolio in Q2 2025.
- Quantessence Capital opened 151 new positions and closed 302 in Q2 2025.
- Quantessence Capital's portfolio value fell 15% quarter-over-quarter to $340M.
Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.